No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase
Background: An increasing number of reports indicates that vaccines against influenza may interact with specific drugs via drug metabolism. To date, actual impact of vaccine-drug interactions observed in the real world clinical practice has not been investigated. Methods: From VAERS and VigiBase, we...
Saved in:
Main Authors: | Carla Carnovale (Author), Emanuel Raschi (Author), Luca Leonardi (Author), Ugo Moretti (Author), Fabrizio De Ponti (Author), Marta Gentili (Author), Marco Pozzi (Author), Emilio Clementi (Author), Elisabetta Poluzzi (Author), Sonia Radice (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature
by: Riccardo Mei, et al.
Published: (2018) -
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
by: Vera Battini, et al.
Published: (2023) -
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System
by: Michele Fusaroli, et al.
Published: (2021) -
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
by: Emanuel Raschi, et al.
Published: (2019) -
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal
by: Emanuel Raschi, et al.
Published: (2022)